Evidence map›Paper›PMID 37818193›Full record

ArticleFrontiers in pharmacology2023

Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.

Irma Convertino, Massimiliano Cazzato, Silvia Tillati, Sabrina Giometto, Rosa Gini, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Marco Bonaso, Claudia Bartolini and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Irma Convertino *Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Massimiliano Cazzato *Unit of Rheumatology, University Hospital of Pisa, Pisa, Italy.
Silvia TillatiUnit of Medical Statistics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Sabrina GiomettoUnit of Medical Statistics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Rosa GiniTuscan Regional Healthcare Agency, Florence, Italy.
Giulia ValdiserraUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Emiliano CappelloUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Sara FerraroUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Marco BonasoUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Claudia BartoliniTuscan Regional Healthcare Agency, Florence, Italy.
Olga PaolettiTuscan Regional Healthcare Agency, Florence, Italy.
Valentina LorenzoniInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Leopoldo TriesteInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Matteo FilippiDirezione Medica di Presidio, University Hospital of Pisa, Pisa, Italy.
Giuseppe TurchettiInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Michele CristofanoDirezione Medica di Presidio, University Hospital of Pisa, Pisa, Italy.
Corrado BlandizziUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Marta MoscaUnit of Rheumatology, University Hospital of Pisa, Pisa, Italy.
Ersilia LucenteforteUnit of Medical Statistics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Marco TuccoriUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
University of Pisa · ITAzienda Ospedaliera Universitaria Pisana · ITAgenzia Regionale di Sanità della Toscana · ITScuola Superiore Sant'Anna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biologicDAS28discontinuationDMARDdrug-utilizationinitiationreal-world

Identifiers

PMID37818193
PMCPMC10561246
OpenAlexW4387058809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.